Drug Delivery Technologies: Nucleic Acid Delivery Players, products & prospects to 2018

Table of Contents

EXECUTIVE SUMMARY & INTRODUCTION

• Overview of delivery technologies for genetic material: past, present & future
• Leading technology platforms for the delivery of genetic material
• Nucleic acid delivery: motivators & resistors

ADVANCED NUCLEIC ACID DELIVERY TECHNOLOGIES

• Types of nucleic acid-based products under development by the pharma industry
• Viral vector delivery of nucleic acids
• Bacterial vector delivery of nucleic acids
• Non-viral vector delivery of nucleic acids
• Chemical Technologies
• Physical Technologies
• Current therapeutic applications for the viral and non-viral delivery of nucleic acids
• Leading nucleic acid-based products in development
• Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

• Leading nucleic acid drug delivery companies
• Strategic developmental & commercialisation partnerships
• Mergers, acquisitions & joint ventures
• Intellectual Property

THE VIRAL AND NON-VIRAL VECTOR DELIVERY MARKET

• Now 2009: Approved nucleic acid product sales
• Future 2018: Novel nucleic acid product sales and Global nucleic acid product sales

COMPETITOR ANALYSIS

Detailed analysis of leading companies covering:

• Proprietary delivery technology
• Applications in the pharma industry
• Management/technical expertise
• Competition within the delivery technology sector
• Products in development/approved utilising the delivery technology
• Sales forecasts of products utilising the delivery technology
• Competitor ratio analysis

Companies analysed

• Alnylam Pharmaceuticals, Inc.
• AlphaVax, Inc.
• Altea Therapeutics, Inc.
• AP Pharma, Inc.
• ArmaGen Technologies, Inc.
• BioDelivery Sciences International, Inc.
• Calando Pharmaceuticals, Inc.
• Cequent Pharmaceuticals, Inc.
• Copernicus Therapeutics, Inc.
• Diatos SA, Inc.
• DOR BioPharma, Inc
• Expression Genetics, Inc
• Inovio Biomedical Corporation
• MaxCyte, Inc
• Nanotherapeutics, Inc.
• NeoPharm, Inc.
• Novagali Pharma, S.A.
• Oxford Biomedica, Plc.
• PCI Biotech ASA.
• Silence Therapeutics, Plc.
• Targeted Genetics Corporation
• TissueGene, Inc.
• Vical, Inc.
• Zosano Pharma, Inc.

APPENDICIES

• Global nucleic acid approved drug sales 2008-2018
• Global nucleic acid development drug sales 2008-2018
• Key nucleic acid delivery companies by 2018